Physician profile
Cathy Lee
NPI 1508448416
$1,184.84
in general payments reported to CMS, 2019-2025
18 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $279 · 2022: $267 · 2023: $77.00 · 2024: $141 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624 · Entertainment: $13.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $623.95 |
| Entertainment | $13.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $358.04 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Dexcom, INC. | $170.96 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $129.81 | 2021-2025 | |
| Glaxosmithkline, LLC. | $70.88 | 2022-2025 | Trelegy Ellipta |
| Amarin Pharma, INC. | $70.07 | 2021-2022 | |
| Astellas Pharma US INC | $63.53 | 2025 | Veozah |
| Amgen INC. | $62.01 | 2021-2022 | |
| Lilly USA, LLC | $54.65 | 2021-2025 | Mounjaro |
| Gilead Sciences, INC. | $48.88 | 2022 | |
| Abbvie INC. | $32.66 | 2024-2025 | |
| Inspire Medical Systems, INC. | $23.47 | 2025 | Inspire |
| Agios Pharmaceuticals, INC. | $20.40 | 2025 | Pyrukynd |
| Linus Health, INC. | $16.98 | 2022 | |
| Novo Nordisk INC | $16.42 | 2023 | Ozempic, Rybelsus |
| Optos, INC. | $13.94 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.78 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.67 | 2021 | |
| Phathom Pharmaceuticals, INC. | $5.69 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cathy Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.